Association of Polymorphisms of Genes Involved in Lipid Metabolism with Blood Pressure and Lipid Values in Mexican Hypertensive Individuals

Table 4

Multiple linear regression models observed in normolipemic and hyperlipemic hypertensive patients.

Variable	Allele	Constant			Subgroups
TC (mg/dL)	LPL p.474X	234.1	−44.5	0.039	Hyperlipemic
LDL-C (mg/dL)	FABP2 p.55T	162.2	−20.7	0.024	Hyperlipemic
HDL-C (mg/dL)	APOA5 p.19W	43.6	8.7	0.007	Normolipemic
TG (mg/dL)	APOA5 p.19W	183.5	52.0	0.023	Hyperlipemic
	APOB p.4181K	114.6	−31.4	0.003	Normolipemic
	FABP2 p.55T	169.2	47.3	0.010	Hyperlipemic
	FABP2 p.55T	142.4	36.5	0.002	Hypertensive
	LDLR c.1959T		−26.3	0.024
	FABP2 p.55T	190.0	53.2	0.003	Hyperlipemic
	LDLR c.1959T		−43.0	0.017
SBP (mmHg)	FABP2 p.55T	147.1	7.9	0.007	Normolipemic
	MTTP −493T	144.2	10.3	0.042	Hyperlipemic

TC: total cholesterol; TG: triglycerides; SBP: systolic blood pressure.